Capital World Investors
LRMR icon

Capital World Investors’s Larimar Therapeutics LRMR Stock Holding History

Capital World Investors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-42,720
Closed -$16.4M – 532
2015
Q3 		$16.4M Sell
42,720
-12,280
-22% -$5.54M ﹤0.01% 443
2015
Q2 		$22.9M Buy
55,000
+4,583
+9% +$1.92M 0.01% 428
2015
Q1 		$24M Buy
50,417
+34,229
+211% +$16.2M 0.01% 428
2014
Q4 		$5.99M Buy
16,188
+5,771
+55% +$1.49M ﹤0.01% 511
2014
Q3 		$2.46M Buy
+10,417
New +$2.36M ﹤0.01% 509

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Capital World Investors's LRMR Position: Q4 2015 in Review

Capital World Investors sold out of Larimar Therapeutics (LRMR) in Q4 2015, closing a stake of 42,720 shares — an estimated $16.4M sold.

Capital World Investors first reported a position in LRMR in Q3 2014 and held it in 5 quarters. The position peaked at $24M in Q1 2015. 87 funds tracked by Wall St. Rank hold LRMR as of Q4 2015.

  • Capital World Investors reported no remaining Larimar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Capital World Investors sold 42,720 Larimar Therapeutics shares in Q4 2015, an estimated $16.4M.
  • Capital World Investors first reported a position in Larimar Therapeutics in Q3 2014 and held it in 5 quarters.
  • Capital World Investors's Larimar Therapeutics position peaked at $24M in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2015.

Based on Capital World Investors's 13F filing for Q4 2015, filed 12 Feb 2016.